 Todos Medical Ltd said its majority-owned joint venture 3CL Pharma Ltd has received a notice of allowance issued by the US patent and trademark office for its TolloTest. The test is designed to detect and quantify 3CL protease in human tissue samples, which is being measured for correlation with infectiousness and is potentially a key feature of the pathology in Long COVID. 